On the treatment of hemorrhage in patients with hemophilia and associated inhibitors.
Tarantino
M
M
Aledort
L
L
D000818:Animals; D001779:Blood Coagulation Factors / Q000627:therapeutic use; D003657:Decision Making; D005167:Factor VII / Q000627:therapeutic use; D005169:Factor VIII / Q000276:immunology / Q000627:therapeutic use; D015942:Factor VIIa; D006467:Hemophilia A / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D007518:Isoantibodies / Q000097:blood; D011994:Recombinant Proteins / Q000627:therapeutic use; D013552:Swine
D001779:Blood Coagulation Factors; D007518:Isoantibodies; D011994:Recombinant Proteins; C025667:prothrombin complex concentrates; D005167:Factor VII; D005169:Factor VIII; C103587:recombinant FVIIa; D015942:Factor VIIa